Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-13-031061

Director bought 120,000 shares

From the SEC's structured data for this filing

Trades in this filing

LICHTINGER PEDRO · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2013-06-04 Purchase : show line 1 in the form +120,000 126,250 D
Open-market purchases · 120,000 sh

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2013-06-04 Purchase : show line 2 in the form Option to Purchase Common Shares +30,000 $5.00 2018-06-04 30,000 30,000 D
Loading xslF345X03/doc4.xml…